Menu
GeneBe

SPRED2

sprouty related EVH1 domain containing 2

Basic information

Region (hg38): 2:65310850-65432637

Links

ENSG00000198369NCBI:200734OMIM:609292HGNC:17722Uniprot:Q7Z698AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Noonan syndrome 14 (Limited), mode of inheritance: AR
  • Noonan syndrome 14 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Noonan syndrome 14ARCardiovascular; Hematologic; OncologicSurveillance and treatment related to manifestations such as cardiac anomalies (which include cardiomyopathy and structural anomalies) may be beneficial; The disorder can include bleeding diathesis, and recognition and preventive measures (eg, in surgical situations) may be beneficialCardiovascular; Craniofacial; Genitourinary; Hematologic; Musculoskeletal; Neurologic34626534

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SPRED2 gene.

  • Inborn genetic diseases (18 variants)
  • not provided (3 variants)
  • Noonan syndrome 14 (2 variants)
  • Noonan syndrome (2 variants)
  • Severe postnatal growth retardation (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SPRED2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
1
clinvar
18
clinvar
19
nonsense
0
start loss
0
frameshift
1
clinvar
1
clinvar
2
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
1
clinvar
1
Total 2 0 19 1 1

Variants in SPRED2

This is a list of pathogenic ClinVar variants found in the SPRED2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-65313538-C-T not specified Uncertain significance (Jul 15, 2021)2237980
2-65313565-C-T not specified Uncertain significance (Oct 13, 2023)3169365
2-65313614-TAA-T Noonan syndrome • Noonan syndrome 14 Pathogenic (Aug 01, 2021)1209657
2-65313620-C-T not specified Uncertain significance (Aug 17, 2022)2307745
2-65313653-T-C not specified Uncertain significance (Jun 06, 2023)2557148
2-65313669-G-T not specified Uncertain significance (Mar 01, 2024)3169364
2-65313726-C-G not specified Uncertain significance (Jun 22, 2023)2605622
2-65313808-T-A not specified Uncertain significance (Dec 18, 2023)3169373
2-65313815-T-A not specified Uncertain significance (Sep 21, 2023)3169372
2-65313815-T-G not specified Uncertain significance (Dec 18, 2023)3169371
2-65313827-A-G not specified Uncertain significance (Sep 25, 2023)3169370
2-65313841-C-T not specified Uncertain significance (Jan 09, 2024)3169369
2-65313866-G-A not specified Uncertain significance (Apr 25, 2023)2550488
2-65313910-C-T not specified Uncertain significance (Sep 17, 2021)2345083
2-65313990-C-G not specified Uncertain significance (Jan 23, 2023)2478148
2-65314030-G-A not specified Uncertain significance (Jan 04, 2024)2218769
2-65314162-G-C not specified Uncertain significance (May 25, 2022)2289701
2-65314163-G-A not specified Uncertain significance (Feb 02, 2022)2275025
2-65314177-G-A Likely benign (Oct 01, 2023)2651009
2-65316739-C-G not specified Uncertain significance (May 03, 2023)2543130
2-65316749-G-T not specified Uncertain significance (Mar 12, 2024)3169368
2-65316754-C-T not specified Uncertain significance (Apr 25, 2022)2285602
2-65316798-C-T not specified Uncertain significance (Aug 21, 2023)2591332
2-65316832-G-A not specified Uncertain significance (Mar 07, 2024)3169367
2-65316858-G-A not specified Uncertain significance (Aug 17, 2021)2385065

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SPRED2protein_codingprotein_codingENST00000356388 6121787
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.87e-70.7651256950531257480.000211
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.312342970.7870.00002102752
Missense in Polyphen64113.380.564481045
Synonymous0.9661161300.8920.0000106798
Loss of Function1.331319.30.6730.00000110203

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0007890.000786
Ashkenazi Jewish0.000.00
East Asian0.0002180.000217
Finnish0.0001390.000139
European (Non-Finnish)0.0002510.000246
Middle Eastern0.0002180.000217
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Negatively regulates Ras signaling pathways and downstream activation of MAP kinases. {ECO:0000269|PubMed:15683364}.;
Pathway
Imatinib and Chronic Myeloid Leukemia;Signal Transduction;Signaling by FGFR;Regulation of RAS by GAPs;KitReceptor;RAF/MAP kinase cascade;MAPK1/MAPK3 signaling;MAPK family signaling cascades;Signaling by Receptor Tyrosine Kinases;Signaling events mediated by Stem cell factor receptor (c-Kit);FGFRL1 modulation of FGFR1 signaling;Signaling by FGFR1 (Consensus)

Recessive Scores

pRec
0.130

Intolerance Scores

loftool
0.377
rvis_EVS
-0.69
rvis_percentile_EVS
15.2

Haploinsufficiency Scores

pHI
0.513
hipred
Y
hipred_score
0.543
ghis
0.599

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.886

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Spred2
Phenotype
limbs/digits/tail phenotype; skeleton phenotype; reproductive system phenotype; hematopoietic system phenotype; growth/size/body region phenotype;

Gene ontology

Biological process
inactivation of MAPK activity;multicellular organism development;fibroblast growth factor receptor signaling pathway;negative regulation of peptidyl-threonine phosphorylation;positive regulation of DNA damage response, signal transduction by p53 class mediator;regulation of protein deacetylation
Cellular component
cytosol;plasma membrane;transport vesicle membrane
Molecular function
stem cell factor receptor binding;protein binding;protein kinase binding;protein serine/threonine kinase inhibitor activity